๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
This phase I study will evaluate the safety and tolerability of an autologo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01022255
Treatments Being Tested
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The Second Affiliated Hospital of SchoowUniversity
Start Date
2023-04-01
Trial ID
NCT05790447
Treatments Being Tested
To determine the safety as well as the most effective dose of sargramostim ...
Status
Completed
Location
USC CRS
Start Date
TBD
Trial ID
NCT00000681
Treatments Being Tested
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
TJ003234RAR101 is a first-in-human (FIH), single-center, randomized, double...
Status
Completed
Location
Pharmaron
Start Date
2019-03-18
Trial ID
NCT03794180
This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Status
Completed
Location
Site 2644 University of California, Irvine
Start Date
2018-06-19
Trial ID
NCT03294083
Treatments Being Tested
Phase I trial to compare the effectiveness of vaccine therapy with or witho...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center at Georgetown University
Start Date
2000-11
Trial ID
NCT00009958
This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Status
Terminated
Location
Ottawa Hospital and Research Institute (OHRI)
Start Date
2011-10
Trial ID
NCT01329809
Treatments Being Tested